Agile Therapeutics, Inc. (AGRX) Financials

Stock symbol AGRX is outdated, potentially delisted? Maybe it is available on other exchange?

AGRX Assets vs Liabilities

Date	Assets	Liabilities
June 30, 2024	15.0 million	36.9 million
March 31, 2024	12.6 million	22.9 million
Dec. 31, 2023	10.3 million	26.6 million
Sept. 30, 2023	10.9 million	23.3 million

AGRX Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.

Date	Free Cash Flow	Stock based compensation
June 30, 2024	233000	285000
March 31, 2024	-2.5 million	333000
Dec. 31, 2023	172000	563000
Sept. 30, 2023	365000	439000

AGRX Net Income

No data available :(

AGRX Cash and Debt

Graph available only for paid members. Upgrade to see it.

Date	Cash	Debt	Capital Lease
June 30, 2024	2.8 million	-	289000
March 31, 2024	2.6 million	-	378000
Dec. 31, 2023	2.6 million	100000	466000
Sept. 30, 2023	2.9 million	196000	549000

AGRX Shares Outstanding

Graph available only for paid members. Upgrade to see it.

Date	Shares Outstanding
June 30, 2024	?
March 31, 2024	4.6 billion
Dec. 31, 2023	3.0 million
Sept. 30, 2023	3.0 million

AGRX Expenses

Graph available only for paid members. Upgrade to see it.

Date	Capex	R&D	G&A	S&M
June 30, 2024	-	538000	6.3 million	3.8 million
March 31, 2024	-	495000	6.3 million	3.7 million
Dec. 31, 2023	-	54000	5.4 million	3.7 million
Sept. 30, 2023	-	705000	7.5 million	4.8 million

AGRX Cost of Revenue

Graph available only for paid members. Upgrade to see it.

Date	Revenue	Cost of Revenue
June 30, 2024	5.6 million	1.5 million
March 31, 2024	5.7 million	1.7 million
Dec. 31, 2023	3.6 million	2.2 million
Sept. 30, 2023	6.7 million	2.5 million

AGRX

Price: $1.51

52 week price:

0.20

2.63

Earnings Per Share: -1.70 USD

P/E Ratio: 0.21

Exchange: OQB

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: United States

Volume: 296349

Ebitda: -6.6 million

Market Capitalization: 10.0 million

Links:

AGRX on Yahoo Finance